These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9471456)

  • 21. Assessing the risk of ovarian hyperstimulation syndrome in egg donation: implications for human embryonic stem cell research.
    Ellison B; Meliker J
    Am J Bioeth; 2011 Sep; 11(9):22-30. PubMed ID: 21877969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Problems associated with assisted reproductive technology program.
    Chang YS
    Nihon Sanka Fujinka Gakkai Zasshi; 1994 Aug; 46(8):637-45. PubMed ID: 8089602
    [No Abstract]   [Full Text] [Related]  

  • 23. Revealing the enigmas of implantation: what is the true impact of ovarian hyperstimulation?
    Oehninger S
    Fertil Steril; 2008 Jan; 89(1):27-30. PubMed ID: 17678916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Multiple pregnancies: epidemiology and management].
    Braat DD; Schönbeck Y; Kremer JA
    Ned Tijdschr Geneeskd; 2003 Oct; 147(40):1952-5. PubMed ID: 14574778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low-dose aspirin for prophylaxis of ovarian hyperstimulation syndrome.
    Várnagy A; Koppan M; Manfai Z; Busznyak C; Bodis J
    Fertil Steril; 2008 Apr; 89(4):1035-6. PubMed ID: 18353319
    [No Abstract]   [Full Text] [Related]  

  • 26. [A child at all costs? At what price? Consequences for the mother].
    Belaisch-Allart J; Mayenga JM
    Contracept Fertil Sex; 1997 Apr; 25(4):279-84. PubMed ID: 9229517
    [No Abstract]   [Full Text] [Related]  

  • 27. [From theory to clinical practice: recombinant FSH in daily practice].
    Kably Ambe A; Barrón Vallejo J; Góngora Rodríguez A; Carballo Mondragón E; Anta Jaén E
    Ginecol Obstet Mex; 1999 Aug; 67():408-13. PubMed ID: 10504796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complications of IVF and ovulation induction.
    Klemetti R; Sevón T; Gissler M; Hemminki E
    Hum Reprod; 2005 Dec; 20(12):3293-300. PubMed ID: 16126753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preliminary observations about assisted reproduction in thalassaemia.
    Negri P; De Sanctis V; Grechi E; Gamberini MR; Urso L
    J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():929-33. PubMed ID: 10091167
    [No Abstract]   [Full Text] [Related]  

  • 30. Serum anti-Müllerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles.
    Lee TH; Liu CH; Huang CC; Wu YL; Shih YT; Ho HN; Yang YS; Lee MS
    Hum Reprod; 2008 Jan; 23(1):160-7. PubMed ID: 18000172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Repetitive oocyte donation.
    Practice Committee of the American Society for Reproductive Medicine
    Fertil Steril; 2006 Nov; 86(5 Suppl 1):S216-7. PubMed ID: 17055825
    [No Abstract]   [Full Text] [Related]  

  • 32. Repetitive oocyte donation.
    Practice Committee of the American Society for Reproductive Medicine
    Fertil Steril; 2004 Sep; 82 Suppl 1():S158-9. PubMed ID: 15363716
    [No Abstract]   [Full Text] [Related]  

  • 33. Assisted conception. III--problems with assisted conception.
    Braude P; Rowell P
    BMJ; 2003 Oct; 327(7420):920-3. PubMed ID: 14563758
    [No Abstract]   [Full Text] [Related]  

  • 34. Oocyte donation.
    Steiner AZ; Paulson RJ
    Clin Obstet Gynecol; 2006 Mar; 49(1):44-54. PubMed ID: 16456342
    [No Abstract]   [Full Text] [Related]  

  • 35. The conundrum of oocyte donation, human research, OHSS, and ethics.
    Stein AL
    Am J Bioeth; 2011 Sep; 11(9):35-7. PubMed ID: 21877972
    [No Abstract]   [Full Text] [Related]  

  • 36. A precautionary approach to oocyte donation for stem cell nuclear transplantation.
    Kalfoglou AL; Sauer MV
    Am J Bioeth; 2011 Sep; 11(9):31-3. PubMed ID: 21877970
    [No Abstract]   [Full Text] [Related]  

  • 37. A prospective trial comparing oocyte donor ovarian response and recipient pregnancy rates between suppression with gonadotrophin-releasing hormone agonist (GnRHa) alone and dual suppression with a contraceptive vaginal ring and GnRH.
    Martínez F; Boada M; Coroleu B; Clua E; Parera N; Rodríguez I; Barri PN
    Hum Reprod; 2006 Aug; 21(8):2121-5. PubMed ID: 16632462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro fertilisation: many unknowns.
    Prescrire Int; 2001 Dec; 10(56):187-8. PubMed ID: 11824446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Harmony and compensation for oocyte providers.
    Batzer F; Daar J
    Am J Bioeth; 2011 Sep; 11(9):39-41. PubMed ID: 21877974
    [No Abstract]   [Full Text] [Related]  

  • 40. Reconsidering risk to women: oocyte donation for human embryonic stem cell research.
    Bamford R
    Am J Bioeth; 2011 Sep; 11(9):37-9. PubMed ID: 21877973
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.